FDA Advisory Committees - FDA Center for Drug Evaluation and Research (CDER) - Oncologic Drugs Advisory Committee (ODAC)

Upcoming Meetings

Past Meetings This Year

Oncologic Drugs Advisory Committee (ODAC)

ODAC reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cancer and makes appropriate recommendations to the Commissioner of Food and Drugs.

FDA Committee Website